Michael Shepard
- Oncology top 10%
- HER2/EGFR in Cancer Research 2
- Immunology top 10%
- Immune Response and Inflammation 2
-
- Monoclonal and Polyclonal Antibodies Research 2
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation 2
- Immunology and Allergy top 10%
-
- Cancer, Hypoxia, and Metabolism 3
-
- Proteoglycans and glycosaminoglycans research 3
-
- Adenosine and Purinergic Signaling 2
-
- Cancer Research and Treatments 2
- Co-authors
- Reinhold MunkerL SouzaHP KoefflerDennis J. SlamonRuth LupuGerhard ZugmaierJay SarupRámón Colomer
- Partner nations
- United StatesItaly
In The Last Decade
Michael Shepard
13 papers receiving 721 citations
Peers
Comparison fields: 5 of 68
- Oncology 380
- Immunology 259
- Radiology, Nuclear Medicine and Imaging 233
- Hematology 105
- Immunology and Allergy 54
Countries citing papers authored by Michael Shepard
This map shows the geographic impact of Michael Shepard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Shepard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Shepard more than expected).
Fields of papers citing papers by Michael Shepard
This network shows the impact of papers produced by Michael Shepard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Shepard. The network helps show where Michael Shepard may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Shepard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 3 | |
| 2 | 2016 | 1 | |
| 3 | 2016 | 8 | |
| 4 | 2011 | 2 | |
| 5 | 2011 | 1 | |
| 6 | 2010 | 1 | |
| 7 | 2004 | 3 | |
| 8 | Radiolabeled antibody targeting of the HER-2/neu oncoprotein. | 1992 | 98 |
| 9 | 1990 | 23 | |
| 10 | 1990 | 252 | |
| 11 | 1989 | 13 | |
| 12 | 1987 | 180 | |
| 13 | 1987 | 162 |
About Michael Shepard
Michael Shepard is a scholar working on Physiology, Cancer Research, Biotechnology, Cell Biology and Oncology, having authored 13 papers that have together received 747 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (3 papers), Proteoglycans and glycosaminoglycans research (3 papers), Adenosine and Purinergic Signaling (2 papers), Cancer Research and Treatments (2 papers), Immune Response and Inflammation (2 papers), HER2/EGFR in Cancer Research (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (380 citations), Immunology (259 citations), Radiology, Nuclear Medicine and Imaging (233 citations), Hematology (105 citations) and Immunology and Allergy (54 citations). Michael Shepard has collaborated with scholars based in United States and Italy. Frequent co-authors include Reinhold Munker, L Souza, HP Koeffler, Dennis J. Slamon, Ruth Lupu, Gerhard Zugmaier, Jay Sarup, Rámón Colomer, Marc E. Lippman and Judith C. Gasson. Their work appears in journals such as Cancer Research, Blood, Journal of Clinical Oncology, Science and Journal of Bone and Mineral Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.